Cost-effectiveness analyses of 20-valent pneumococcal conjugate vaccine in children and adults: A narrative review
Many pneumococcal vaccines have been developed. Economic evaluation provides a framework to inform decision-making. Cost-effectiveness analysis (CEA) studies on 20-valent pneumococcal conjugate vaccine (PCV20) have been published. We introduce the concept of health economics and the basic framework...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2025-12-01
|
| Series: | Human Vaccines & Immunotherapeutics |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/21645515.2025.2525619 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|